Roth Capital Initiates Celladon At Buy
Analysts at Roth Capital initiated coverage on Celladon Corporation (NASDAQ: CLDN) with a Buy rating.
Celladon shares have gained 70.15% over the past 52 weeks, while the S&P 500 index has surged 11.80% in the same period.
Celladon’s shares rose 10.69% to $21.75 in pre-market trading.
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.